Hong Kong start-up aims to lower cost of early autism detection using whole genome sequencing

MSN News

31st August 2023

Hong Kong start-up aims to lower cost of early autism detection using whole genome sequencing

A diagnostics start-up in Hong Kong is aiming to make it affordable to identify autism risks in infants and toddlers, as recent technological advances significantly lower the cost of whole genome sequencing-based disease detection.

BlueSky Precision Medicine, established in January this year and accepted by Hong Kong’s government-funded tech hub Cyberport in May, is providing a set of tests for children under 18 months with a family history of autism that could determine their risks of developing the disorder.

Traditionally, treatments can only be provided to autistic children above 2 years old who already display full-scale symptoms.

https://www.msn.com/en-xl/news/other/hong-kong-start-up-aims-to-lower-cost-of-early-autism-detection-using-whole-genome-sequencing/ar-AA1g0MIc